Literature DB >> 1648728

Retinoic acid is a negative regulator of AP-1-responsive genes.

R Schüle1, P Rangarajan, N Yang, S Kliewer, L J Ransone, J Bolado, I M Verma, R M Evans.   

Abstract

We present evidence that retinoic acid can down-regulate transcriptional activation by the nuclear protooncogene c-jun. All three members of the retinoic acid receptor (RAR) subfamily (RAR alpha, RAR beta, and RAR gamma) can repress transcriptional induction of the human collagenase gene or a heterologous promoter that contains the collagenase promoter AP-1-binding site. In contrast, the retinoid X receptor fails to repress Jun/AP-1 activity, demonstrating a significant difference between the two regulatory systems through which retinoids exert their transcriptional control. Analysis of RAR alpha mutants in transfection studies reveals that the DNA-binding domain is important for the inhibition of Jun/AP-1 activity, even though the RAR does not bind the collagenase AP-1 site. Rather, gel-retardation assays reveal that bacterially expressed full-length RAR alpha inhibits binding of Jun protein to target DNA. These data suggest that the RAR alpha may form a nonproductive complex with c-Jun and provides a simple mechanisms by which retinoic acid may limit cell growth and possibly malignant progression.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1648728      PMCID: PMC52028          DOI: 10.1073/pnas.88.14.6092

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Coordinate regulation of stromelysin and collagenase genes determined with cDNA probes.

Authors:  S M Frisch; E J Clark; Z Werb
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

Review 2.  A human retinoic acid receptor which belongs to the family of nuclear receptors.

Authors:  M Petkovich; N J Brand; A Krust; P Chambon
Journal:  Nature       Date:  1987 Dec 3-9       Impact factor: 49.962

3.  The induction of differentiation in teratocarcinoma stem cells by retinoic acid.

Authors:  S Strickland; V Mahdavi
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

4.  Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor.

Authors:  P Angel; M Imagawa; R Chiu; B Stein; R J Imbra; H J Rahmsdorf; C Jonat; P Herrlich; M Karin
Journal:  Cell       Date:  1987-06-19       Impact factor: 41.582

5.  Coordinate occupancy of AP-1 sites in the vitamin D-responsive and CCAAT box elements by Fos-Jun in the osteocalcin gene: model for phenotype suppression of transcription.

Authors:  T A Owen; R Bortell; S A Yocum; S L Smock; M Zhang; C Abate; V Shalhoub; N Aronin; K L Wright; A J van Wijnen
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

6.  Cloning of the genes for human stromelysin and stromelysin 2: differential expression in rheumatoid synovial fibroblasts.

Authors:  K L Sirum; C E Brinckerhoff
Journal:  Biochemistry       Date:  1989-10-31       Impact factor: 3.162

7.  Characterization of DNA binding and retinoic acid binding properties of retinoic acid receptor.

Authors:  N Yang; R Schüle; D J Mangelsdorf; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

8.  Cooperativity of the glucocorticoid receptor and the CACCC-box binding factor.

Authors:  R Schüle; M Muller; H Otsuka-Murakami; R Renkawitz
Journal:  Nature       Date:  1988-03-03       Impact factor: 49.962

9.  Identification of a second human retinoic acid receptor.

Authors:  N Brand; M Petkovich; A Krust; P Chambon; H de Thé; A Marchio; P Tiollais; A Dejean
Journal:  Nature       Date:  1988-04-28       Impact factor: 49.962

10.  Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an AP1 binding site.

Authors:  R C Nicholson; S Mader; S Nagpal; M Leid; C Rochette-Egly; P Chambon
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

View more
  115 in total

1.  Modulation of CRX transactivation activity by phosducin isoforms.

Authors:  X Zhu; C M Craft
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

2.  Cytoplasmic catalytic subunit of protein kinase A mediates cross-repression by NF-kappa B and the glucocorticoid receptor.

Authors:  V Doucas; Y Shi; S Miyamoto; A West; I Verma; R M Evans
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

3.  Terminal differentiation in keratinocytes involves positive as well as negative regulation by retinoic acid receptors and retinoid X receptors at retinoid response elements.

Authors:  B J Aneskievich; E Fuchs
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

4.  A negative retinoic acid response element in the rat oxytocin promoter restricts transcriptional stimulation by heterologous transactivation domains.

Authors:  S M Lipkin; C A Nelson; C K Glass; M G Rosenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

5.  Regulated expression of the human acetylated low density lipoprotein receptor gene and isolation of promoter sequences.

Authors:  K S Moulton; H Wu; J Barnett; S Parthasarathy; C K Glass
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

6.  Retinoic acid repression of bone morphogenetic protein 4 in inner ear development.

Authors:  Deborah L Thompson; Lisa M Gerlach-Bank; Kate F Barald; Ronald J Koenig
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

7.  Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells.

Authors:  Z Dong; M J Birrer; R G Watts; L M Matrisian; N H Colburn
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

8.  Retinoic acid prevents experimental Cushing syndrome.

Authors:  M Páez-Pereda; D Kovalovsky; U Hopfner; M Theodoropoulou; U Pagotto; E Uhl; M Losa; J Stalla; Y Grübler; C Missale; E Arzt; G K Stalla
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

9.  Two silencing sub-domains of v-erbA synergize with each other, but not with RXR.

Authors:  B Martin; R Renkawitz; M Muller
Journal:  Nucleic Acids Res       Date:  1994-11-25       Impact factor: 16.971

10.  Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro.

Authors:  T K Kerppola; D Luk; T Curran
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.